XML 150 R134.htm IDEA: XBRL DOCUMENT v3.3.1.900
Parent Corporation Only Financial Statements (Details) - Condensed Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2014
Sep. 30, 2014
Jun. 30, 2014
Mar. 31, 2014
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Cash flows from operating activities:                        
Net income $ 9,568 $ 10,842 $ 10,521 $ 10,379 $ 8,023 $ 1,766 $ 4,378 $ 4,398 $ 41,311 $ 18,565 $ 19,925  
Adjustments to reconcile net income to net cash provided by operating activities:                        
Increase in other assets                 1,190 2,200 414  
Decrease in other liabilities                 (1,080) 377 (1,792)  
Stock based compensation                 747 223 59  
Cash flows from financing activities:                        
Cash dividends on common stock                 (8,996) (6,940) (4,254)  
Cash dividends on preferred stock                 (112) (140) (141)  
Proceeds from exercise of stock options                 1,424 885 21  
Decrease in cash and cash equivalents                 74,048 44,155 (23,446)  
Cash and cash equivalents at beginning of year 200,895       126,847       200,895 126,847 82,692 $ 106,138
Cash and cash equivalents at end of year 200,895       126,847       200,895 126,847 82,692  
Parent Company [Member]                        
Cash flows from operating activities:                        
Net income                 $ 41,311 $ 18,565 19,925  
Adjustments to reconcile net income to net cash provided by operating activities:                        
Net gains on sales of available for sale securities                 (22)  
Equity in undistributed earnings of subsidiary                 $ (32,472) $ (9,890) (15,916)  
Increase in other assets                 (820) (1,979) (167)  
Decrease in other liabilities                 (1,840) (1,010) (276)  
Stock based compensation                 747 223 59  
Net cash provided by operating activities                 $ 6,926 $ 5,909 3,603  
Cash flows from investing activities:                        
Proceeds from sales of available-for-sale securities                 $ 181  
Capital infusion to subsidiary                 $ (35,000)  
Net cash provided by (used in) investing activities                 (35,000) $ 181  
Cash flows from financing activities:                        
Proceeds from subordinated debt                 50,000  
Cash dividends on common stock                 (8,996) $ (6,940) $ (4,254)  
Cash dividends on preferred stock                 $ (112) $ (140) (141)  
Issuance of restricted stock award                 243  
Issuance cost of common stock                 $ (7) (13)  
Proceeds from exercise of stock options                 $ 1,424 885 21  
Tax expense from stock based compensation                 341 282 16  
Net cash used in financing activities                 42,657 (5,920) (4,128)  
Decrease in cash and cash equivalents                 14,583 (11) (344)  
Cash and cash equivalents at beginning of year 14,857       274       14,857 274 285 $ 629
Cash and cash equivalents at end of year $ 14,857       $ 274       $ 14,857 $ 274 $ 285